Article
[BRCA mutations: from Angelina Jolie to specific therapies].
Revue medicale suisse - 18 May 2016
Lopez Veronica Aedo, Stravodimou Athina, Unger Sheila, Perey Lucien, Zaman Khalil
Abstract excerpt
While mutations in BRCA1 and BRCA2 are found in only a minority of breast cancer patients, their impact for those patients is important. It is a powerful risk factor for this disease with respectively 65% and 45% of the women developing breast cancer. It requires a specific screening program starting at age of 25 that includes magnetic resonance imaging and risk reduction measures such as bilateral mastectomy and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
